Atenolol (Page 7 of 7)

Cessation of Therapy in Patients with Angina Pectoris

If withdrawal of atenolol therapy is planned, it should be achieved gradually and patients should be carefully observed and advised to limit physical activity to a minimum.

HOW SUPPLIED

Atenolol tablets, USP for oral administration, are supplied as:

50 mg: round, white, scored tablets debossed GG 263 on one side and plain on the reverse side, and supplied as:

NDC 63187-201-30 bottles of 30

NDC 63187-201-60 bottles of 60

NDC 63187-201-90 bottles of 90

Store at 20°-25°C (68°-77°F) (see USP Controlled Room Temperature).

Dispense in a tight, light-resistant container.

11-2012M

7249

Sandoz Inc.

Princeton, NJ 08540

Repackaged By:

Proficient Rx LP

Thousand Oaks, CA 91320

50 mg Label

NDC 63187-201-90

Atenolol

Tablets, USP

50 mg

Rx only

30 Tablets

ATENOLOL atenolol tablet

Product Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:63187-201(NDC:0781-1506) Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ATENOLOL (ATENOLOL) ATENOLOL 50 mg

Inactive Ingredients Ingredient Name Strength MICROCRYSTALLINE CELLULOSE MAGNESIUM STEARATE SILICON DIOXIDE SODIUM STARCH GLYCOLATE TYPE A POTATO

Product Characteristics Color WHITE Score 2 pieces Shape ROUND Size 7mm Flavor Imprint Code GG263 Contains

Packaging # Item Code Package Description Multilevel Packaging 1 NDC:63187-201-30 30 TABLET in 1 BOTTLE None 2 NDC:63187-201-60 60 TABLET in 1 BOTTLE None 3 NDC:63187-201-90 90 TABLET in 1 BOTTLE None

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA073025 09/17/1991

Labeler — Proficient Rx LP (079196022)

Establishment
Name	Address	ID/FEI	Operations
Proficient Rx LP		079196022	REPACK (63187-201), RELABEL (63187-201)

Revised: 01/2021 Proficient Rx LP